NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-209-2016-0-NZ-17 IMMUNOGLOBULIN SINGLE VARIABLE DOMAIN ANTIBODY AGAINST RSV PREFUSION F PROTEIN NZ National Stage 738300 Abandoned
NIBIB E-143-2015-0-US-04 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE IN THE PRODUCTION OF LONG-ACTING THERAPEUTICS US National Stage 15/735,687 10709790 Issued PDF
NCI E-151-2011-0-US-05 REDUCTION OF TGF BETA SIGNALING IN MYELOID CELLS IN THE TREATMENT OF CANCER US DIV 15/837,905 Abandoned
NINDS E-130-2022-3-HK-01 OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE HK EP 62020005213.7 Issued
NINDS E-130-2022-3-EP-01 OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE EP National Stage 17879038.2 Issued
NINDS E-130-2022-3-CN-01 OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE CN National Stage 201780084881.1 Issued
NINDS E-130-2022-3-JP-01 OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE JP National Stage 2019-530702 Issued
NINDS E-130-2022-3-IL-02 OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE IL DIV 2057-08-29 Issued
NINDS E-130-2022-3-MX-01 OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE MX National Stage MX/a/2019/006694 Issued
NINDS E-130-2022-3-AU-01 OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE AU National Stage 2017370731 Issued
NINDS E-130-2022-3-IL-01 OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE IL National Stage 267134 Issued
NINDS E-130-2022-3-PC-01 OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE PCT PCT COMB PCT/US2017/065270 Expired
NIA E-092-2011-0-US-10 THE USE OF (2R, 6R)-HYDROXYNORKETAMINE, (S)-DEHYDRONORKETAMINE AND OTHER STEREOISOMERIC DEHYDRO AND HYDROXYLATED METABOLITES OF (R,S)- KETAMINE IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN US CON 15/836,396 Abandoned
NIDA E-049-2015-0-US-04 METHOD AND SYSTEM FOR A MOBILE HEALTH PLATFORM US National Stage 15/580,975 Abandoned
NINDS E-130-2022-3-IN-01 OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE IN National Stage 201917023002 Abandoned
NINDS E-130-2022-3-BR-01 OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE BR National Stage 112019011627-3 Pending
NINDS E-130-2022-3-KR-01 OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE KR National Stage 10-2019-7019763 Pending
NINDS E-130-2022-3-CA-01 OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE CA National Stage 3046515 Pending
NCI E-240-2015-1-US-05 METHODS OF ANALYZING VIRUS-DERIVED THERAPEUTICS US National Stage 15/580,299 10662464 Issued PDF
NCI E-085-2013-0-JP-10 Methods of Producing Enriched Populations of Tumor Reactive T Cells from Peripheral Blood JP DIV 2017-233698 Issued
NIDA E-073-2013-0-US-08 POTENT AND SELECTIVE INHIBITORS OF MONOAMINE TRANSPORTERS; METHOD OF
MAKING; AND USE THEREOF 		US DIV 15/830,244 10590074 Issued PDF
NCI E-238-2017-0-US-01 METHODS OF ENRICHING CELL POPULATIONS FOR CANCER-SPECIFIC T CELLS USING IN VITRO STIMULATION OF MEMORY T CELLS US 62/594,262 Abandoned
NCI E-239-2017-0-US-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS US 62/594,244 Abandoned
NCI E-267-2014-0-US-07 PROCESSES FOR PRODUCTION AND PURIFICATION OF NUCLEIC ACID-CONTAINING COMPOSITIONS US National Stage 15/579,137 10954492 Issued PDF
NIAAA E-282-2012-1-US-08 CANNABINOID RECEPTOR MEDIATING COMPOUNDS US National Stage 15/579,123 Abandoned
NINR E-223-2018-0-US-01 Rapid nucleic acids separation/sample preparation via the hollow-centered silica microsphere US 62/593,598 Abandoned
NICHD E-003-2018-0-US-01 AUTOPHAGY MODULATORS FOR USE IN TREATING CANCER US 62/593,579 Abandoned
NINDS E-113-2011-0-US-07 Wirelessly Powered Magnetic Resonance Imaging Signal Amplification System US DIV 15/825,316 10203382 Issued PDF
NIBIB E-135-2015-0-EP-03 Organotrifluoroborate Mimics of Amino Acids and Uses Thereof EP National Stage 16787230.8 Abandoned
NCI E-004-2018-1-US-01 HOIP-BASED POLYPEPTIDES AND THEIR USES US 62/592,260 Abandoned
NCI E-004-2018-0-US-01 HOIP-BASED POLYPEPTIDES AND THEIR USES US 62/592,006 Abandoned
NCI E-137-2016-0-US-01 Microbicidal Composition US 62/591,569 Abandoned
NIAMS E-024-2018-0-US-01 Compounds, Compositions, and Methods for Treating And/Or Preventing Periodontal Disease US 62/590,824 Abandoned
NCI E-090-2013-0-AU-07 Systems and Methods of Video Monitoring for Vivarium Cages AU DIV 2017265176 Abandoned
NHLBI E-122-2006-0-US-05 COMPOSITIONS AND METHODS FOR PREVENTION OR TREATMENT OF NEOPLASTIC DISEASE IN A MAMMALIAN SUBJECT US DIV 15/821,523 10214726 Issued PDF
NCI E-096-2017-0-US-03 Next Generation Human Papilloma Virus Typing US National Stage 15/575,977 Abandoned
NIDCR E-026-2018-0-US-01 USE OF COPEPTIN TO INDUCE HEMATOPOIESIS US 62/587,784 Abandoned
NCI E-105-2012-0-CN-11 Murine Anti-NY-ESO-1 T Cell Receptors CN DIV 201711136635.4 Issued
NINR E-134-2015-0-US-03 Paper Strip Tool With Gold Nanoparticle Conjugated Probes For Rapid Detection Of Pathogens In Stool US National Stage 15/574,750 Abandoned
NCI E-085-2013-0-US-09 METHODS OF PRODUCING ENRICHED POPULATIONS OF TUMOR REACTIVE T CELLS FROM PERIPHERAL BLOOD US DIV 15/813,398 10716809 Issued PDF
NIAID E-086-2018-3-EP-03 Zika Viral Antigen Constructs EP National Stage 17804131.5 Pending
NCI E-150-2017-2-NZ-12 Diagnostic Methods For T Cell Therapy NZ National Stage 737358 Pending
NCI E-282-2016-2-NZ-16 Methods of conditioning Patients For T Cell Therapy NZ National Stage 737359 Abandoned
NIAID E-086-2018-3-PCT-01 Zika Viral Antigen Constructs PCT PCT COMB PCT/EP2017/079343 Expired
NCI E-267-2014-0-SG-06 PROCESSES FOR PRODUCTION AND PURIFICATION OF NUCLEIC ACID-CONTAINING COMPOSITIONS SG National Stage 11201709382T Pending
NHLBI E-078-2015-0-JP-06 Three-Dimensional Right Atrial Appendage Curve Catheter JP National Stage 2017-559396 Issued
NCI E-087-2015-1-US-03 METHODS AND COMPOSITIONS FOR INDUCING AN IMMUNE RESPONSE USING
CONSERVED ELEMENT CONSTRUCTS 		US National Stage 15/573,701 Pending
NIDA E-005-2018-0-US-01 ATYPICAL INHIBITORS OF MONOAMINE TRANSPORTERS; METHOD OF MAKING; AND USE THEREOF US 62/585,058 Abandoned
NIDCR E-175-2015-1-US-05 AAV ISOLATE AND FUSION PROTEIN COMPRISING NERVE GROWTH FACTOR SIGNAL PEPTIDE AND PARATHYROID HORMONE US National Stage 15/573,214 11447797 Issued PDF
NCI E-016-2018-0-US-01 CHIMERIC ANTIGEN RECEPTORS TARGETING TUMOR ANTIGENS US 62/584,421 Abandoned